Autism is a neurological disorder affecting the behaviour of the individual, in which the patient is devoid from social and verbal interaction.
Synapses are the connectors of brain cells. The brain receives the stimuli through synapses.
Researchers from the University of Columbia in New York have said that the increase in the number of synapses is not the actual cause but the cause behind the overproduction of synapses is the issue. It is said that old synapses are unable to degrade resulting in increase in the production of synapses.
The researchers used experimental drug rapamycin in mice. Rapamycin contains mTOR blocker which is a protein. The drug was seen helpful in reducing the hyperactivity of autistic brain by restricting the synapses activity by blocking the protein mTOR.
Researcher’s confirmed that after the druge rapamycin was injected to the mice, the austistic behaviour activity was found to be reduced. The experimental drug is not yet tested on humans. However the recent findings among mice is definitely going to open a new door for the treatment of Autism.
The details about the study and its findings were published in US Journal of Neurons.